RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Clinical trial NCT06359041 · RECRUITING
Trial details
- NCT number
- NCT06359041
- Sponsor
- Cabaletta Bio
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2029-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.